Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells
{{output}}
CRISPR-Cas9 genome editing has enabled advanced T cell therapies, but occasional loss of the targeted chromosome remains a safety concern. To investigate whether Cas9-induced chromosome loss is a universal phenomenon and evaluate its clinical significance, we ... ...
